Very Short Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients With High Bleeding Risk

Authors:

Abstract
Optimal antithrombotic therapy after percutaneous coronary interventions in high bleeding risk (HBR) patients is an important issue under active discussion. However, no previous study has compared ...